Janssen Plans Tiered Pricing For Sirturo In India; Will Work With Government Agencies For Right Use
This article was originally published in PharmAsia News
Executive Summary
The TB treatment will be brought to India with a tiered-pricing mechanism, but Janssen says it will work with partners to ensure appropriate use in a country with the highest population of MDR-TB patients.
You may also be interested in...
TB Drug Headed Toward Accelerated Approval: Another Wrinkle for Priority Review Vouchers
A positive advisory committee for Janssen’s bedaquiline means the second priority review voucher is probably on its way. And it would be the first for an accelerated approval.
India's Open Source Drug Discovery Initiative Compiles The TB Genome; Calls For Stronger Global Partnerships For Leads
MUMBAI - A decade after the mycobacterium tuberculosis genome sequence was deciphered, the Indian government's ambitious Open Source Drug Discovery initiative released what is claimed to be the first-ever comprehensive compilation of the mapped TB genome. The collated data will be made available through an open public portal for further analysis, leads and research collaborations
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.